SKILLMAN, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) (“Kenvue”), the world’s largest pure-play consumer health company by revenue, today announced its Neutrogena® brand is taking dermatological beauty to the next level by establishing multi-year partnerships with Dr. Dhaval Bhanusali, renowned skincare innovator, and Dr.

新泽西州斯基尔曼（商业新闻短讯）--Kenvue Inc.（纽约证券交易所代码：KVUE）（“Kenvue”）是世界上收入最大的纯游戏消费者健康公司，今天宣布其露得清®品牌通过与著名护肤创新家Dhaval Bhanusali博士和Dr。

Muneeb Shah, the most followed dermatologist worldwide2..

穆尼布·沙阿（Muneeb Shah），世界上最受欢迎的皮肤科医生2。。

This collaboration reinforces Neutrogena®’s commitment to fusing beauty and science to deliver advanced clinical efficacy and extraordinary product experiences. It also builds on existing partnerships with a diverse network of global dermatologists who are actively involved in product development, clinical studies, and educational initiatives.

这一合作加强了露得清®融合美容和科学的承诺，以提供先进的临床疗效和非凡的产品体验。它还建立在与全球皮肤科医生的多样化网络的现有合作关系的基础上，这些网络积极参与产品开发，临床研究和教育计划。

Looking ahead, Neutrogena® aims to advance the science of dermatology to better address gaps in the category and help shape the future of skincare by increasing collaboration with the dermatologist community..

展望未来，Neutrogena®旨在推动皮肤病学的发展，通过加强与皮肤科医生的合作，更好地填补该领域的空白，并帮助塑造皮肤护理的未来。。

“We look forward to strengthening our leadership in dermatological beauty and deepening our connections with the healthcare professional community, retailers and consumers,” said Chris Riat, Global Neutrogena® Brand Leader. “We are excited to work closely with leading experts like Dr. Bhanusali and Dr.

全球露得清®品牌领导者克里斯·里亚特（ChrisRiat）表示：“我们期待着加强我们在皮肤美容领域的领导地位，加深我们与医疗保健专业团体、零售商和消费者的联系。”。“我们很高兴能与Bhanusali博士和Dr。

Shah, who share our passion for advancing dermatological science and obsession with product formulation and experience.”.

沙阿（Shah），他与我们一样热衷于推进皮肤科学，并痴迷于产品配方和经验。”。

Dr. Bhanusali is a pivotal figure in the global skincare industry and a renowned skincare formulator.

Bhanusali博士是全球护肤行业的关键人物，也是著名的护肤配方设计师。

Dr. Shah is widely recognized for his insights on consumer behavior and for successfully using social media to make dermatology accessible.

沙阿博士因其对消费者行为的见解以及成功利用社交媒体使皮肤病学变得可及而广受认可。

Together, they are raising the profile of dermatology and reshaping its importance in skin health and beauty.

他们共同提高了皮肤病学的知名度，重塑了其在皮肤健康和美容中的重要性。

As Global Innovation Partners, they will work with Neutrogena® in three areas:

作为全球创新合作伙伴，他们将在三个领域与露得清®合作：

Innovation acceleration: partnering with the Company’s R&D teams to both advance clinical science and improve product experience

创新加速：与公司研发团队合作，推进临床科学，改善产品体验

Consumer engagement: building a proactive and engaged community of consumers and influencers

消费者参与：建立一个由消费者和影响者组成的积极参与的社区

Dermatologist collaboration: exploring new ways to partner with the dermatologist community

皮肤科医生合作：探索与皮肤科医生社区合作的新方式

“From inception to the moment consumers use the products for the first time, I am proud to help Neutrogena craft the future of beauty,” said Dr. Bhanusali. “This partnership represents a true shift in skincare, one where brands truly lean into science and partner with dermatologists to better care for their patients and consumers everywhere.'.

Bhanusali博士说：“从一开始到消费者第一次使用这些产品的那一刻，我很自豪能帮助露得清打造美丽的未来。”。“这种合作关系代表了护肤领域的真正转变，品牌真正专注于科学，并与皮肤科医生合作，更好地照顾各地的患者和消费者。”。

“Dermatologist-led innovation is central to Neutrogena’s identity, and I’m proud to support the brand in developing next-generation solutions for our patients,” shared Dr. Shah. “Through this partnership we hope to reinforce Neutrogena's unwavering commitment to both dermatologists and patients, shaping the future of science-backed beauty.'.

Shah博士分享道：“皮肤科医生主导的创新是露得清身份的核心，我很自豪能够支持该品牌为我们的患者开发下一代解决方案。”。“通过这种合作关系，我们希望加强露得清对皮肤科医生和患者的坚定承诺，塑造科学支持的美丽未来。”。

About Kenvue

关于Kenvue

Kenvue is the world's largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand, Johnson's®, Listerine®, Neutrogena® and Tylenol®, are science-backed and recommended by healthcare professionals around the world.

Kenvue是世界上收入最大的纯游戏消费者健康公司。基于一个多世纪的传统，我们的标志性品牌，包括Aveeno®、BAND-AID®品牌、Johnson®、Listerine®、Neutrogena®和Tylenol®，得到了世界各地医疗保健专业人士的科学支持和推荐。

At Kenvue, we believe in the extraordinary power of everyday care and our teams work every day to put that power in consumers' hands and earn a place in their hearts and homes. Learn more at www.kenvue.com..

在肯维，我们相信日常护理的非凡力量，我们的团队每天都在努力将这种力量放在消费者手中，并在他们的心中和家中赢得一席之地。更多信息，请访问www.kenvue.com。。

About Neutrogena®

关于露得清®

For over 90 years, Neutrogena® has made sophisticated science simple, developing solutions for everyday skincare that balance clinical efficacy with elegant aesthetics. From science-backed innovation to accessible education, we are driven by a mission to democratize skin health. Our products address skin needs across ages, skin types and tones.

90多年来，露得清（Neutrogena®）将复杂的科学变得简单，为日常护肤品开发解决方案，平衡临床功效和优雅美学。从科学支持的创新到普及教育，我们的使命是使皮肤健康民主化。我们的产品满足不同年龄段、不同皮肤类型和肤色的皮肤需求。

Neutrogena® is a brand of Kenvue Brands LLC, a subsidiary of Kenvue Inc..

露得清®是Kenvue Brands LLC的一个品牌，Kenvue Brands LLC是Kenvue Inc.的子公司。。

1

1

Based on Nielsen sales data for the 52 weeks ending 9/7/24

根据尼尔森公司截至2014年9月7日52周的销售数据

2

2

Based on Dr. Shah’s combined Instagram and TikTok reach

基于Shah博士的Instagram和TikTok reach的组合

Cautions Concerning Forward-Looking Statements

关于前瞻性陈述的注意事项

This press release contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 regarding a multi-year collaboration with Dr. Muneeb Shah and Dr. Dhaval Bhanusali to deliver advanced clinical efficacy and extraordinary product experiences for the Neutrogena® brand.

本新闻稿包含1995年《私人证券诉讼改革法案》中定义的“前瞻性声明”，涉及与Muneeb Shah博士和Dhaval Bhanusali博士的多年合作，为Neutrogena®品牌提供先进的临床疗效和非凡的产品体验。

Forward-looking statements may be identified by the use of words such as “plans,” “expects,” “will,” “anticipates,” “estimates” and other words of similar meaning. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events.

前瞻性陈述可以通过使用“计划”、“预期”、“将”、“预期”、“估计”等词语和其他类似含义的词语来识别。提醒读者不要依赖这些前瞻性陈述。这些声明基于当前对未来事件的预期。

If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Kenvue and its affiliates. Risks and uncertainties include, but are not limited to: the potential that the expected benefits and opportunities related to the collaboration may not be realized or may take longer to realize than expected; challenges inherent in new product development, including the uncertainty of clinical success and obtaining regulatory approvals; competition, including technological advances, new products and intellectual property attained by competitors; uncertainty of commercial success for new products; the ability of Kenvue to successfully execute strategic plans; impact of business combinations and divestitures; challenges to intellectual property; and changes in behavior and spending patterns or financial distress of consumers.

如果基础假设被证明不准确或已知或未知的风险或不确定性出现，实际结果可能与Kenvue及其附属公司的预期和预测有很大差异。风险和不确定性包括但不限于：与合作相关的预期利益和机会可能无法实现或可能需要比预期更长的时间才能实现；新产品开发固有的挑战，包括临床成功和获得监管批准的不确定性；竞争，包括竞争对手取得的技术进步、新产品和知识产权；；Kenvue成功执行战略计划的能力；企业合并和资产剥离的影响；知识产权面临的挑战；以及行为和消费模式的变化或消费者的财务困境。

A further list and descriptions of these risks, uncertainties and other factors can be found in Kenvue’s filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the fiscal year ended December 31, 2023, a.

有关这些风险、不确定性和其他因素的更多列表和描述，请参阅Kenvue向美国证券交易委员会提交的文件，包括其截至2023年12月31日的10-K表年度报告。